By 2025, the clinical integration of marijuana for inflammation is predicted to see significant shifts. Researchers suggest targeted products, potentially featuring novel CBD mixtures and controlled delivery systems, https://speedgreens.co/treating-arthritis-with-cannabis-in-2025/